Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The party is not over and neither is QMC Health! Clinical trials in May! SEC registration soon to follow.
$5+
https://www.qmc-health.com/
How about just forgiving the convertible debt. A long shot and certainly any of us would have a hard time deciding to let an asset dissolve. It would help the pps but in al honesty a buyout/merger is an option as well? JMO the company has a ton of value but requires the perfect partner?
$TILLABELIEVER$
Coming out shortly!
$5+
Forgiveness of the convertible debt may be necessary for even Kelly to redeem her shares for
any value?
You said it more bullshit!
$5-$10+
So what is our investment worth? The pps bid is .19 and some recall 2. per share as a rumored past buyout price? (Neither of any consequence IMO) Nothing to confirm this but some at one point on the board stated 2 billion for the company was a steal or for 229.5 million or $8.71 per share. NOW for the projected value of the hemostasis market review here....... WE ARE SPOT ON! Not withstanding the advent of a production/buyout $15 is conceivable!
5-$10+
https://www.yahoo.com/now/hemostasis-products...00011.html
Some major findings of the hemostasis products market report include:
Growing number of product launches (Hemostyp) and technological advances will spur the business landscape.
Rising adoption of advanced technologies in production of hemostasis products will foster market demand.
Increasing number of road traffic accidents will stimulate the market statistics.
Rise in number of varied surgical procedures across developing countries will be a major factor impacting the market revenue.
So what is our investment worth? The pps bid is .19 and some recall 2. per share as a rumored past buyout price? (Neither of any consequence IMO) Nothing to confirm this but some at one point on the board stated 2 billion for the company was a steal for 229.5 million or $8.71 per share. NOW for the projected value of the hemostasis market review here....... WE ARE SPOT ON! Not withstanding the advent of a production partner/buyout $15 is conceivable! BTW a production partner as the company has mentioned on multiple occasions is already in place!
5-$10+
https://www.yahoo.com/now/hemostasis-products...00011.html
Some major findings of the hemostasis products market report include:
Growing number of product launches (Hemostyp) and technological advances will spur the business landscape.
Rising adoption of advanced technologies in production of hemostasis products will foster market demand.
Increasing number of road traffic accidents will stimulate the market statistics.
Rise in number of varied surgical procedures across developing countries will be a major factor impacting the market revenue.
Yes your correct I recall finding the company moving production from China to Maryland in
February 2020 right when covid hit the states. We have come a long way and Brian connecting with RCA was a great move IMO!
$5-$10+
Amid all the quack posts!!
STILLABELIEVER$$
.10+
Guess you didn't get out? Oops!
Would've, could've, should've serve no purpose except to appease your emotional distress. Doug if he new about RCA would have engaged them earlier IMO. Brian certainly perceived FDA with blinders on and was not prepared for the job so I give him a b- for effort but getting us across the plate is the bottom line. Engaging RCA IMO will be his saving grace. Stay the course and keep buying is my recommendation. I only blame myself for staying in the game!
$5-$10+
Not surprising that shorties have been attacking the pps.
SHORT INTEREST
DATE SHORT INTEREST % CHANGE AVG. DAILY SHARE VOL DAYS TO COVER SPLIT NEW ISSUE
01/31/2023 123,282 12.15 318,679 1 No No
01/13/2023 109,929 -22.99 363,596 1 No No
12/30/2022 142,742 21.66 554,253 1 No No
12/15/2022 117,333 11.55 343,895 1 No No
11/30/2022 105,184 -2.15 300,584 1 No No
11/15/2022 107,493 -9.97 115,340 1 No No
10/31/2022 119,400 9.40 119,600 1 No No
10/14/2022 109,143 5.92 463,562 1 No No
09/30/2022 103,043 -6.16 195,368 1 No No
09/15/2022 109,806 -6.27 89,023 1.23 No No
$5-$10+
Lets just remember who is in our corner! Filled with former FDA employees!
https://www.rcainc.com/medical-device/
Just think what would Rocky Balboa say....
“Going in one more round when you don’t think you can. That’s what makes all the difference in your life.” – Rocky Balboa “
$5-$10+
Old Rod sold at the right time! Guess you missed the bus!
Every share is bot at a discount! So your value in your investment will just continue to grow!
$5-$10+
Bargain buys!
$5-$10+
$5-$10+
Nice volume from some savy investor!
$5-$10+
I like your assessment! Whether one batch of production was run the FDA requests for multiple runs are the most significant. Also a third party big pharm is watching, waiting and even more interested in my opinion. A billion dollar++ market share is worth the wait and White Lions $350,000 investment and now amended agreement is evidence of their positive d/d!
We are building value!
$5-$10+
No to r/s no to dilution yes to merger/buyout/partner production agreement!!!
$5-$10+
Funny no one bashes a good stock! .25 again will be cheap when the pps hits $5.
$5-$10+
Sure like the value increasing in my Etrade account.
$5-$10+
White Lion may have as also become more optimistic in the PMA FDA approval?
$5-$10+
Here's some positive news for you Chrism!!!
Check your Etrade or other brokerage news!
Separately, in September 2022 the company entered into a Common Stock Purchase Agreement with White Lion Capital, LLC under which the company has the right to sell shares of its common stock to White Lion at a price equal to 93% of the five-day volume weighted average trading price. The company has successfully raised over $350,000 to fund its operations under the Agreement. The Agreement contains a condition that the company share price must be above $0.25 per share (the Floor Price) in order to issue a share purchase notice, which White Lion can waive at its discretion. On January 25, 2023, the company and White Lion amended the Agreement such that if the company issues a purchase notice when its shares are trading below the Floor Price and White Lion waives the Floor Price condition, White Lion's purchase price per share in that transaction will be 90% of the five-day volume weighted average trading price rather than 93%. All other terms of the Agreement remain unchanged. Basically this is what has created the recent floor IMO! (the Floor Price) Sounds like White Lion's believes in Hempotyp!
$5-$10+
STILLABELIEVER$$
$1+
Newbies....https://uhpcorp.com/investor-relations/
$5-$10+
Hey Dr good to see your still around like the rest of the good old boys!
Check it out and render your opinion?
https://www.nasdaq.com/market-activity/stocks/ueec/sec-filings
https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&ref=117170987&type=PDF&symbol=UEEC&companyName=United+Health+Products+Inc&formType=4&formDescription=Statement+of+changes+in+beneficial+ownership+of+securities&dateFiled=2023-01-17&CK=1096938
https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&ref=117170998&type=PDF&symbol=UEEC&companyName=United+Health+Products+Inc&formType=5&formDescription=Annual+statement+of+changes+in+beneficial+ownership+of+securities&dateFiled=2023-01-17&CK=1096938
Brian is acquiring more shares!
$5-$10+
Perseverance will pay off for investors!
$5+
STILLABELIEVER$$$
$5-$10+
SHORT INTEREST
DATE SHORT INTEREST % CHANGE AVG. DAILY SHARE VOL DAYS TO COVER SPLIT NEW ISSUE
12/30/2022 142,742 21.66 554,253 1 No No
12/15/2022 117,333 11.55 343,895 1 No No
11/30/2022 105,184 -2.15 300,584 1 No No
11/15/2022 107,493 -9.97 115,340 1 No No
10/31/2022 119,400 9.40 119,600 1 No No
10/14/2022 109,143 5.92 463,562 1 No No
09/30/2022 103,043 -6.16 195,368 1 No No
09/15/2022 109,806 -6.27 89,023 1.23 No No
08/31/2022 117,155 2.68 229,174 1 No No
08/15/2022 114,102 -18.66 259,166 1 No No
Thanks Phillippe!
Yes and some savvy investors are buying!! Someone just filled a 37000 order?
$5-$10+
Still to harsh IMO! Without covid we would be in the money by now! JMO!
Chill out everyonel!
$5-$10+
Supplements have a fast track non PMA procedure!
$5-$10+
Thanks for your perspective! I still believe a buyout of $5-$10 is realistic and will depend upon buyer required thresholds to be achieved to meet the pps price! In that regard the real value is in the gel and foam product yet to be developed to our knowledge! IMO this will require a FDA approval albeit a stream - lined approval process. (The FDA has a pathway for approving biosimilars that demonstrates they are highly similar to an already-approved biological product and have no clinically meaningful differences in terms of safety and effectiveness from the reference product.)
$5-$10+
I did receive a reply from IR but nothing of substance or did they in anyway
allude to a new listing or partner agreements.
$5+
Perseverance pays off if you are still invested!
$5+
Nice reminder that UEEC has always complied to all specific FDA technical requests! Facts matter!
$5-$10+
$5-$10+
Happy new year! UEEC near FDA approval!
Someone picked up 50000 near the close! News?
$5-$10+